In addition, 25.0%, 77.6% and 73.7% of NSCLC specimens with high miR-128-3p expression exhibited high levels of E-cadherin, Vimentin and endothelial marker CD34, respectively. The gene discussed is CDH1; the disease is non-small cell lung carcinoma.